Technology
Health
Pharmaceutical

Allakos

$31.71
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.13 (0.41%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Allakos and other stocks, options, ETFs, and crypto commission-free!

About ALLK

Allakos Inc. Common Stock, also called Allakos, is AK002, a monoclonal antibody used for the treatment of various eosinophil and mast cell related diseases such as eosinophilic gastritis, urticaria, severe allergic conjunctivitis, and indolent systemic mastocytosis. Read More The company was founded by Christopher Bebbington, Nenad Tomasevic, Bruce S. Bochner, and Robert Schleimer in 2012 and is headquartered in Redwood, CA.

Employees
62
Headquarters
Redwood, California
Founded
2012
Market Cap
1.36B
Price-Earnings Ratio
Dividend Yield
Average Volume
374.19K
High Today
$32.68
Low Today
$31.31
Open Price
$31.86
Volume
463.98K
52 Week High
$65.48
52 Week Low
$29.34

Collections

Technology
Health
Pharmaceutical
2018 IPO
US
North America

ALLK Earnings

-$0.47
-$0.42
-$0.36
-$0.31
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Jul 26, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.